2004~2010年鲍曼不动杆菌医院感染及耐药性变化(3)
 |
| 第1页 |
参见附件。
[3] Urban C，Maurer-Segal，Rahal JJ. Considerations in control and transmission of nosocomial infections due to multi-drug resistant?Acinetobacter baumannii [J]. Clin Infect Dis，2003，36：1268-1274.
[4] Hsueh PR，Liu YC，Yang D，et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan [J]. Microb Drug Resist，2001，7：373-382.
[5] Bergogne-Berezin E，Towner KJ.Acinetobacter spp.as nosocomial pathogens： microbiological，clinical，and epidemiological features [J]. Clin Microbiol Rev，1996，9：148-165.
[6] Bergogne-Berezin E，Joly-Guillou ML，Vieu JF. Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus [J]. J Hosp Infect，1987，10：105-113.
[7] Hartstein A，Rashad IA，Liebler LJM， et al. Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated，reusable ventilator circuits and resuscitationbags [J]. Am J Med，1988，85：624-631.
[8] Wood GC，Hanes SD，Croce MA，et al. Comparison of ampicillin-sulbactam and imipenem-cilastatin for thetreatment of Acinetobacter ventilator associated pneumonia [J]. ClinicalInfectious Diseases，2002，34：1425-1430.
[9] Urban C，Go E，Mariano N，et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus [J]. J Infect Dis，1993，167：448–451.
[10] Boucher HW，Talbot GH，Bradley JS，et al. Bad bugs，no drugs：no ESKAPE!An update from the Infectious Diseases Society of America [J]. Clin Infect Dis，2009，48：1-12.
[11] 王云凤,刘奕.我院鲍曼不动杆菌的耐药情况分析及对策[J].临床误诊误治，2012,25(2)：46-48.
[12] Fournier PE，Richet H. The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities [J]. Clin Infect Dis，2006，42：692-699.
[13] Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting [J]. Critical Care August，2001，5 (4)：189-195.
(收稿日期：2012-03-23 本文编辑：程 铭)
您现在查看是摘要介绍页，详见PDF附件(3194kb)。